Mental Health

Latest News

Reassessing Antidepressant Efficacy: A Meta-Analysis of Control Group Outcomes in SSRI, Psilocybin, and Esketamine Trials
Reassessing Antidepressant Efficacy: A Meta-Analysis of Control Group Outcomes in SSRI, Psilocybin, and Esketamine Trials

July 31st 2025

A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.

Confronting the Maternal Mortality Crisis in the United States: Insights From the 2025 Commonwealth Fund Brief
Confronting the Maternal Mortality Crisis in the United States: Insights From the 2025 Commonwealth Fund Brief

July 30th 2025

The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities

July 30th 2025

AJMC
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder

July 23rd 2025

National Minority Mental Health Month. | Image Credit:  juandy -  stock.adobe.com
Addressing Racial Disparities in Minority Mental Health and Finding Support in 2025

July 18th 2025

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo